- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT01959126
Health Enhancement And Resilience Training (HEART)
The Effect of a Stress Reduction Program Using Mindfulness Techniques on Markers of Cellular Stress and Aging
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
This stress-reduction intervention was added into an ongoing observational study in May of 2013. The parent study is a prospective cohort study of the effects of chronic stress in a group of maternal caregivers with children on the autism spectrum and healthy controls whose children have no diagnosis. Study participants are being invited to enroll in a 12-week stress reduction course based on the principles of mindfulness. They will attend four six-hour workshops and participate in 12 weekly hour-long web video conferencing calls to reinforce what is taught in the workshops.
At the beginning and the end of the intervention, they complete self-report measures of psychological well-being and give saliva samples. Since the women are also participating in the longitudinal study, we have other before and after data for them. These include psycho-social measures, body measurements, psycho-physiology measurements, cognitive tests, actigraphy (for sleep), as well as saliva (for hormones), hair (for hormones) and blood (for telomeres, telomerase, gene expression, circulating hormones, inflammation and oxidative stress).
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
California
-
San Francisco, California, Estados Unidos, 94118
- University of California, San Francisco
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Must have at least one child between 2 and 16 at time of enrollment
- Caregivers must have a child diagnosed in that age range diagnosed with an autism spectrum disorder.
- Controls must have a healthy child in that age range. All women must be
Exclusion Criteria:
- Chronic disease, including recent history of cancer
- History of psychiatric disorder, such as bipolar disorder or post-traumatic stress disorder
- Medications, including statins, anti-anxiety drugs, and for controls only anti-depressants.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Stress-reduction class
Study participants enrolled in a 12-week stress reduction course based on the principles of mindfulness.
They attended four six-hour workshops and participated in 12 weekly hour-long web video conferencing calls to reinforce what was taught in the workshops.
We have two groups: chronically-stressed maternal caregivers of children on the autism spectrum and control mothers whose children have no significant psychiatric or physical impairment.
|
Study participants enrolled in a 12-week stress reduction course based on the principles of mindfulness.
They attended four six-hour workshops and participated in 12 weekly hour-long web video conferencing calls to reinforce what was taught in the workshops.
We have two groups: chronically-stressed maternal caregivers of children on the autism spectrum and control mothers whose children have no significant psychiatric or physical impairment.
Both groups received similar instruction.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Salivary telomere length
Prazo: Change from beginning to end of 12-week intervention
|
Participants will give saliva samples at the beginning and the end of the intervention.
Salivary telomere length will be analyzed at both time points.
|
Change from beginning to end of 12-week intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Psychological Well-Being
Prazo: Change from beginning to end of 12-week intervention
|
We will collect perceived stress, acceptance and awareness of emotions and rumination at the beginning and at the end of the intervention.
|
Change from beginning to end of 12-week intervention
|
|
Telomere length from blood cells
Prazo: Change over six months pre- and post-intervention
|
Since participants are also taking part in an ongoing non-interventional longitudinal study, they will provide blood samples at their 18-month study visit, which occurs before the start of the intervention, and at the 24-month study visit, which occurs after the end of the intervention.
We will measure telomere length pre- and post-intervention in a variety of blood cell types.
|
Change over six months pre- and post-intervention
|
|
Telomerase
Prazo: Change over 6 months pre- and post-intervention
|
Since participants are also taking part in an ongoing non-interventional longitudinal study, they will provide blood samples at their 18-month study visit, which occurs before the start of the intervention, and at the 24-month study visit, which occurs after the end of the intervention.
We will measure telomerase pre- and post-intervention in a variety of blood cell types.
|
Change over 6 months pre- and post-intervention
|
|
Cognitive functioning
Prazo: Change over six months pre- and post-intervention
|
Since participants are also taking part in an ongoing non-interventional longitudinal study, they will complete a battery of cognitive tasks at their 18-month study visit, which occurs before the start of the intervention, and at the 24-month study visit, which occurs after the end of the intervention.
We will be able to assess performance pre- and post-intervention, to see if it improves after the stress-reduction training.
|
Change over six months pre- and post-intervention
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Elissa S Epel, PhD, University of California, San Francisco
- Investigador principal: Elizabeth Blackburn, PhD, University of California, San Francisco
- Investigador principal: Jue Lin, PhD, University of California, San Francisco
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 10-02063
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .